×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions for Revance Therapeutics, Inc. (RVNC)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentMar 18, 2024Sale$5.049,21146,446167,550Mar 19, 2024, 06:45 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentMar 15, 2024Option Exercise$5.302,96715,740176,761Mar 19, 2024, 06:45 PM
RVNCRevance Therapeutics, Inc.Moxie DwightCLO & GCMar 15, 2024Option Exercise$5.303,26917,342145,940Mar 19, 2024, 06:44 PM
RVNCRevance Therapeutics, Inc.Moxie DwightCLO & GCMar 18, 2024Sale$5.048,12540,971137,815Mar 19, 2024, 06:44 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOMar 15, 2024Option Exercise$5.303,82220,276202,027Mar 19, 2024, 06:44 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOMar 18, 2024Sale$5.049,36147,204192,666Mar 19, 2024, 06:44 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOMar 15, 2024Option Exercise$5.3020,533108,9281,012,163Mar 19, 2024, 06:43 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOMar 06, 2024Buy$6.9830,000209,4001,015,468Mar 08, 2024, 04:33 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentDec 31, 2023Option Exercise$7.472641,972157,618Jan 03, 2024, 04:50 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEODec 31, 2023Option Exercise$7.472641,972914,718Jan 03, 2024, 04:47 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentDec 15, 2023Option Exercise$8.084,71238,073157,354Dec 18, 2023, 04:32 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretarySep 06, 2023Sale$17.0611,000187,70444,066Sep 07, 2023, 05:37 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretarySep 05, 2023Sale$17.8123,853424,92055,066Sep 07, 2023, 05:37 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOAug 11, 2023Option Exercise$18.9111,215212,07691,301Aug 15, 2023, 04:16 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretaryAug 11, 2023Option Exercise$18.919,592181,38578,919Aug 15, 2023, 04:15 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentAug 11, 2023Option Exercise$18.918,901168,318162,066Aug 15, 2023, 04:15 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOAug 11, 2023Option Exercise$18.9148,064908,890914,454Aug 15, 2023, 04:15 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOAug 03, 2023Sale$22.5726,279593,151840,375Aug 04, 2023, 05:07 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOJun 30, 2023Option Exercise$15.6176912,00181,597Jul 05, 2023, 09:11 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOJul 03, 2023Sale$25.041,70142,59379,896Jul 05, 2023, 09:11 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentJun 30, 2023Option Exercise$15.611,00015,606148,347Jul 05, 2023, 09:11 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOJun 30, 2023Option Exercise$15.611,00015,606892,933Jul 05, 2023, 09:11 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOJul 03, 2023Sale$24.9426,279655,333866,654Jul 05, 2023, 09:11 PM
RVNCRevance Therapeutics, Inc.Kolaja Carey OConnorDirectorJun 15, 2023Sale$23.185,000115,90019,061Jun 20, 2023, 04:25 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentJun 09, 2023Sale$30.825,000154,096147,347Jun 13, 2023, 08:09 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOJun 09, 2023Sale$30.7231,279960,928891,933Jun 13, 2023, 08:09 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOJun 01, 2023Sale$30.572,70182,57081,328Jun 05, 2023, 06:06 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOJun 02, 2023Sale$31.0050015,50080,828Jun 05, 2023, 06:06 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretaryMay 15, 2023Sale$34.5521,401739,33869,165May 16, 2023, 08:29 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOMay 15, 2023Sale$34.5521,401739,33884,029May 16, 2023, 08:29 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOMay 15, 2023Sale$34.5570,4472,433,726923,212May 16, 2023, 08:29 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentMay 15, 2023Sale$34.5521,015726,003152,347May 16, 2023, 08:29 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOMay 01, 2023Sale$31.703,201101,47263,081May 02, 2023, 04:01 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOApr 03, 2023Sale$32.153,201102,91266,282Apr 04, 2023, 04:24 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOMar 15, 2023Option Exercise$30.655,341163,702818,010Mar 17, 2023, 03:22 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOMar 15, 2023Option Exercise$30.653,739114,60069,483Mar 17, 2023, 03:21 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretaryMar 15, 2023Option Exercise$30.657,330224,66448,217Mar 17, 2023, 03:21 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentMar 15, 2023Option Exercise$30.652,96790,939120,967Mar 17, 2023, 03:21 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretaryMar 09, 2023Sale$31.5918,496584,22055,547Mar 09, 2023, 09:46 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOMar 09, 2023Sale$31.5918,517584,88473,222Mar 09, 2023, 09:46 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentMar 09, 2023Sale$31.5921,508679,358123,934Mar 09, 2023, 09:45 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOMar 09, 2023Sale$31.5970,3902,223,360823,351Mar 09, 2023, 09:45 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOMar 01, 2023Sale$33.503,201107,23449,390Mar 02, 2023, 09:25 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentFeb 15, 2023Option Exercise$33.212,76691,85993,046Feb 16, 2023, 08:29 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOFeb 15, 2023Option Exercise$33.212,08569,24352,591Feb 16, 2023, 08:28 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOFeb 01, 2023Sale$34.603,201110,75554,676Feb 02, 2023, 09:38 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOJan 20, 2023Sale$31.001,00031,00057,877Jan 23, 2023, 05:35 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOJan 09, 2023Sale$27.163,701100,52560,877Jan 10, 2023, 08:06 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFODec 31, 2022Option Exercise$12.186457,85662,578Jan 03, 2023, 04:29 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentDec 31, 2022Option Exercise$12.186057,36995,812Jan 03, 2023, 04:28 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEODec 31, 2022Option Exercise$12.186057,369718,092Jan 03, 2023, 04:28 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFODec 15, 2022Option Exercise$21.501,55733,47661,933Dec 16, 2022, 04:12 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentDec 15, 2022Option Exercise$21.502,91662,69495,207Dec 16, 2022, 04:11 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOOct 13, 2022Option Exercise$26.9749,2741,328,920717,487Oct 14, 2022, 07:02 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretarySep 14, 2022Sale$27.0711,000297,79831,694Sep 16, 2022, 04:55 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEOJun 30, 2022Option Exercise$11.751,00011,747766,761Jul 05, 2022, 06:15 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentJun 30, 2022Option Exercise$11.751,00011,74798,123Jul 05, 2022, 06:15 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOJun 30, 2022Option Exercise$11.7596511,33663,490Jul 05, 2022, 06:15 PM
RVNCRevance Therapeutics, Inc.Joshi AbhayCOO, President of R&DMar 15, 2022Option Exercise$15.792,60741,165120,708Mar 17, 2022, 05:56 PM
RVNCRevance Therapeutics, Inc.Foley Mark JChief Executive OfficerMar 15, 2022Option Exercise$15.793,30452,170765,761Mar 17, 2022, 05:54 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretaryMar 15, 2022Option Exercise$15.795,11080,68744,923Mar 17, 2022, 05:52 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyDirectorMar 15, 2022Option Exercise$15.791,37221,66494,091Mar 17, 2022, 05:50 PM
RVNCRevance Therapeutics, Inc.Schilke TobinChief Financial OfficerMar 15, 2022Option Exercise$15.792,60741,16562,525Mar 17, 2022, 05:48 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentMar 15, 2022Option Exercise$15.791,83528,97597,123Mar 17, 2022, 05:43 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentFeb 15, 2022Option Exercise$13.352,42932,42799,253Feb 17, 2022, 08:54 PM
RVNCRevance Therapeutics, Inc.Joshi AbhayCOO, President, R&DFeb 15, 2022Option Exercise$13.355,05367,458126,217Feb 17, 2022, 08:51 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOFeb 15, 2022Option Exercise$13.352,92439,03565,815Feb 17, 2022, 08:49 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFODec 31, 2021Option Exercise$13.874045,60468,056Jan 04, 2022, 08:58 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFODec 15, 2021Option Exercise$15.921,55624,77267,652Dec 17, 2021, 05:31 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SPresidentDec 15, 2021Option Exercise$15.925138,167101,387Dec 17, 2021, 05:29 PM
RVNCRevance Therapeutics, Inc.Russell Angus C.DirectorDec 13, 2021Buy$15.746,400100,74126,913Dec 15, 2021, 08:17 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechDec 03, 2021Buy$14.4330,000432,87695,463Dec 06, 2021, 08:34 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEONov 29, 2021Buy$12.9040,000515,924110,913Nov 29, 2021, 09:24 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEO & PresidentOct 13, 2021Option Exercise$23.0842,096971,576769,065Oct 15, 2021, 08:00 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretarySep 27, 2021Sale$30.001,67550,25047,804Sep 28, 2021, 09:23 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechAug 15, 2021Option Exercise$26.024,949128,77374,827Aug 17, 2021, 06:20 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechAug 16, 2021Sale$26.349,364246,65965,463Aug 17, 2021, 06:20 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechJul 28, 2021Sale$30.0034,3321,029,960321,611Jul 30, 2021, 08:57 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechJul 28, 2021Sale$30.1520,000603,000154,302Jul 30, 2021, 08:57 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechJul 26, 2021Sale$29.7255,3821,645,953355,943Jul 28, 2021, 09:48 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SChief Commercial OfficerJun 30, 2021Option Exercise$24.0988221,24665,980Jul 02, 2021, 07:56 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOJun 30, 2021Option Exercise$24.0944610,74469,208Jul 02, 2021, 07:53 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEO & PresidentJun 30, 2021Option Exercise$24.0988221,246811,161Jul 02, 2021, 07:52 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SChief Commercial OfficerApr 15, 2021Option Exercise$28.1641111,57465,098Apr 16, 2021, 08:17 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechApr 05, 2021Sale$28.28257411,325Apr 06, 2021, 07:41 PM
RVNCRevance Therapeutics, Inc.Moxie DwightSVP, GC & SecretaryMar 15, 2021Option Exercise$27.732,88179,89049,479Mar 17, 2021, 07:29 PM
RVNCRevance Therapeutics, Inc.Joshi AbhayCOO, President, R&DMar 15, 2021Option Exercise$27.731,35437,546128,368Mar 17, 2021, 07:27 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechMar 04, 2021Sale$25.4333,119842,216411,327Mar 05, 2021, 08:10 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFOFeb 15, 2021Option Exercise$28.972,65776,97370,735Feb 19, 2021, 08:15 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SChief Commercial OfficerFeb 15, 2021Option Exercise$28.972,41069,81867,644Feb 19, 2021, 08:13 PM
RVNCRevance Therapeutics, Inc.Joshi AbhayCOO, President, R&DFeb 15, 2021Option Exercise$28.974,848140,447132,603Feb 19, 2021, 08:10 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechFeb 01, 2021Sale$25.9533,119859,438444,446Feb 03, 2021, 08:13 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFODec 31, 2020Option Exercise$21.3649310,53148,799Jan 04, 2021, 08:02 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechDec 30, 2020Sale$27.8233,119921,212477,565Jan 04, 2021, 08:01 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SChief Commercial OfficerDec 31, 2020Option Exercise$21.363487,43345,299Jan 04, 2021, 07:59 PM
RVNCRevance Therapeutics, Inc.Schilke TobinCFODec 15, 2020Option Exercise$26.751,55641,62348,306Dec 22, 2020, 08:39 PM
RVNCRevance Therapeutics, Inc.Sjuts Dustin SChief Commercial OfficerDec 15, 2020Option Exercise$26.7556215,03444,951Dec 22, 2020, 08:37 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechNov 30, 2020Sale$23.8533,119789,888510,684Dec 02, 2020, 08:55 PM
RVNCRevance Therapeutics, Inc.Rankin AubreyPresident, Innovation & TechOct 29, 2020Sale$26.1533,119865,949543,803Oct 30, 2020, 08:24 PM
RVNCRevance Therapeutics, Inc.Foley Mark JCEO & PresidentOct 13, 2020Option Exercise$27.6266,1061,825,848769,564Oct 15, 2020, 06:57 PM